Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
25°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about JNJ
Recent news which mentions JNJ
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Should You Buy Novavax Stock After This Regulatory Win?
September 13, 2024
Tickers
BNTX
JNJ
MRNA
NVAX
Tags
NVAX
Market News
BNTX
From
Motley Fool
Unpacking the Latest Options Trading Trends in Johnson & Johnson
September 12, 2024
Tickers
JNJ
Tags
Market News
Markets
Options
From
Benzinga
Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry
September 12, 2024
Tickers
JNJ
NEWS
Tags
JNJ
BZI/IA
Trading Ideas
From
Benzinga
How To Earn $500 A Month From Johnson & Johnson Stock
September 12, 2024
Tickers
JNJ
NEWS
Tags
News
JNJ
Trading Ideas
From
Benzinga
Metals in Tampons: FDA Initiates New Safety Measures and Testing
September 11, 2024
Tickers
EPC
JNJ
KMB
NEWS
Tags
PG
General
FDA
From
Benzinga
Sony Music-Universal Music JV Hits Johnson & Johnson With Copyright Lawsuit Over Unlicensed Music Use Covering 80 Videos
September 11, 2024
Tickers
JNJ
NEWS
Tags
Media
Legal
General
From
Benzinga
Johnson & Johnson's Mid-Stage Lung Cancer Trial Reveals Fewer Infusion-Related Reactions
September 11, 2024
Tickers
JNJ
NEWS
Tags
General
Briefs
Biotech
From
Benzinga
Is Hims & Hers Health the Next Teladoc?
September 11, 2024
Tickers
HIMS
JNJ
LLY
MRNA
Tags
PFE
Recent Press Releases
TGT
From
Motley Fool
2 Stocks That Are Passive Income Machines to Buy and Hold Forever
September 11, 2024
Tickers
ABT
JNJ
Tags
JNJ
ABT
Recent Press Releases
From
Motley Fool
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
September 10, 2024
Tickers
JNJ
NEWS
PTGX
TAK
Tags
PTGX
Initiation
Analyst Ratings
From
Benzinga
Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart
September 10, 2024
Tickers
JNJ
KVUE
Tags
KVUE
Golden Cross
General
From
Benzinga
Dell, CoStar, PayPal And A Major Health Care Stock On CNBC's 'Final Trades'
September 06, 2024
Tickers
AAPL
CSGP
DELL
JNJ
Tags
News
Karen Firestone
Trading Ideas
From
Benzinga
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
September 06, 2024
Tickers
CVS
JNJ
NEWS
PDCO
Tags
Analyst Ratings
Wall Street's Most Accurate Analysts
PDCO
From
Benzinga
Johnson & Johnson Raises Talc Settlement Offer to $9B, Moves Closer to Settlement Victory
September 05, 2024
Tickers
JNJ
NEWS
Tags
Market News
Large Cap
News
From
Benzinga
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
Tickers
ABBV
ATAI
CMPS
COMP
Tags
ATAI Life Sciences
PFE
MNMD
From
Benzinga
2 Dividend Stocks With Payouts That May Not Be as Safe as They Seem
September 05, 2024
Tickers
INTC
JNJ
MO
WBA
Tags
MO
INTC
JNJ
From
Motley Fool
Court Orders Johnson & Johnson To Compensate Auris Health Shareholders $1B
September 04, 2024
Tickers
JNJ
NEWS
Tags
News
Large Cap
AI Generated
From
Benzinga
3 Dividend Stocks to Double Up on Right Now
September 04, 2024
Tickers
JNJ
NKE
VZ
Tags
Recent Press Releases
VZ
Market News
From
Motley Fool
Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs
September 03, 2024
Tickers
AMGN
AZN
BMY
JNJ
Tags
AI Generated
Top Stories
Regulations
From
Benzinga
Critical Insights From Johnson & Johnson Analyst Ratings: What You Need To Know
September 03, 2024
Tickers
JNJ
Tags
BZI/AAR
Analyst Ratings
Market News
From
Benzinga
Is Johnson & Johnson the Best Dividend Stock for You?
September 01, 2024
Tickers
JNJ
Tags
JNJ
Market News
Recent Press Releases
From
Motley Fool
Worried About a Stock Market Sell-Off? Consider Coca-Cola, Pepsi, and These 3 Safe Dividend Kings for Decades of Passive Income.
September 01, 2024
Tickers
AMZN
CELH
ITW
JNJ
Tags
KO
Market News
PEP
From
Motley Fool
Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps
August 30, 2024
Tickers
ACI
JNJ
KVUE
NEWS
Tags
Health Care
JNJ
Top Stories
From
Benzinga
Johnson & Johnson's Golden Cross: A Bullish Prescription For Investors?
August 29, 2024
Tickers
JNJ
Tags
Market News
Health Care
JNJ
From
Benzinga
Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
August 29, 2024
Tickers
ARGX
JNJ
NEWS
UCBJF
Tags
General
FDA
UCBJY
From
Benzinga
Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry
August 29, 2024
Tickers
JNJ
NEWS
Tags
Markets
Market News
News
From
Benzinga
Spotlight on Johnson & Johnson: Analyzing the Surge in Options Activity
August 28, 2024
Tickers
JNJ
Tags
JNJ
Options
Benzinga
From
Benzinga
12 Dividend Stocks to Earn Income Every Month
August 28, 2024
Tickers
AAPL
AVGO
HD
JNJ
Tags
HD
SBUX
MO
From
Motley Fool
3 Ways the Democratic Party's Platform Could Impact Biotech and Pharma Stocks if Implemented
August 27, 2024
Tickers
JNJ
MRK
PFE
Tags
MRK
PFE
JNJ
From
Motley Fool
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder
August 27, 2024
Tickers
ADXN
INDV
JNJ
NEWS
Tags
JNJ
Health Care
Top Stories
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.